A typology of scientific breakthroughs by Mignon Wuestman, Jarno Hoekman, Koen Frenken

Get full text

The geographical distribution of leadership in globalized clinical trials. by Jarno Hoekman, Koen Frenken, Dick de Zeeuw, Hiddo Lambers Heerspink

Get full text

The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders. by Bauke Schievink, Hiddo Lambers Heerspink, Hubert Leufkens, Dick De Zeeuw, Jarno Hoekman

Get full text

The contribution of Ghanaian patients to the reporting of adverse drug reactions: a quantitative and qualitative study by Tom G. Jacobs, H. Hilda Ampadu, Jarno Hoekman, Alexander N. O. Dodoo, Aukje K. Mantel-Teeuwisse

Get full text

Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences by H. Hilda Ampadu, Jarno Hoekman, Daniel Arhinful, Marilyn Amoama-Dapaah, Hubert G. M. Leufkens, Alex N. O. Dodoo

Get full text

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe by Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels, Andre W. Broekmans, Hubert G.M. Leufkens, Olaf H. Klungel

Get full text

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs by Rick A. Vreman, Lourens T. Bloem, Stijn van Oirschot, Jarno Hoekman, Menno E. van der Elst, Hubert GM Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel-Teeuwisse

Get full text

Associations between uncertainties identified by the European Medicines Agency and national decision making on reimbursement by HTA agencies by Lourens T. Bloem, Rick A. Vreman, Niels W. L. Peeters, Jarno Hoekman, Menno E. van derElst, Hubert G. M. Leufkens, Olaf H. Klungel, Wim G. Goettsch, Aukje K. Mantel‐Teeuwisse

Get full text